From genome to drug lead: Identification of a small-molecule inhibitor of the SARS virus
- 15 February 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (4) , 830-833
- https://doi.org/10.1016/j.bmcl.2005.11.018
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell linesBiochemical and Biophysical Research Communications, 2004
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004
- Characterization of SARS‐CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence‐based assayFEBS Letters, 2004
- Evaluation of metal‐conjugated compounds as inhibitors of 3CL protease of SARS‐CoVFEBS Letters, 2004
- Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptidePublished by Elsevier ,2004
- “Teaching old drugs to kill new bugs”: structure-based discovery of anti-SARS drugsBiochemical and Biophysical Research Communications, 2004
- HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirusBiochemical and Biophysical Research Communications, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Chemical database techniques in drug discoveryNature Reviews Drug Discovery, 2002